Palgic and Pregnancy
Since no adequate studies have been performed on pregnancy and Palgic, the full risks of using this medication during pregnancy are not known at this time. If you are taking this medication and pregnancy occurs, your healthcare provider will weigh the benefits and potential risks before making a recommendation for your particular situation.
Palgic® (carbinoxamine maleate) is a prescription antihistamine medication approved for treating allergies. At this time, it is unknown if this medication is safe for use during pregnancy.
The U.S. Food and Drug Administration (FDA) uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but do appear to cause harm to the fetus in animal studies. Also, medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.
Palgic was assigned a Category C rating because it has not been adequately studied in any pregnant women or animals.
It is important to note that animals do not always respond to medicines in the same way that humans do. Therefore, a pregnancy Category C medicine may be given to a pregnant woman if a healthcare provider believes that the benefits to the pregnant woman outweigh any possible risks to the unborn child.
If you are pregnant or thinking of becoming pregnant while taking Palgic, let your healthcare provider know. He or she will consider both the benefits and risks before making a recommendation for your particular situation.